Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01630421

Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

The goal of this research study is to identify genes and regulatory elements on chromosomes that cause ACC. The investigators also study tissue samples from patients to learn about the processes that lead to this disorder.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Connecticut Health Center

Farmington, Connecticut, 06030, United States

Location status: Recruiting

Location contact

Ernst J Reichenberger, PhD

CONTACT

[email protected]

860-679-2062

About this study

Aplasia cutis congenita (ACC) or congenital scalp defect is a very rare disorder that affects bone and skin. The definition for ACC is the localized absence of (normal) skin at the time of birth (congenital). The skin appears thinner and the underlying structures are visible. We study mostly the isolated form of ACC with the lesion often being at the vertex of the skull (at or close to the top of the skull). The bone underlying the lesion is sometimes thinner as well.

For this study we will:

  • Send out study participation kits and consent by phone
  • Collect a saliva sample from eligible individuals
  • Obtain information regarding ACC
  • Document disorder with photos and doctor's letters
  • If patients undergo surgery for ACC we ask to obtain some tissue that would otherwise be discarded
  • Isolate DNA from the saliva sample
  • Perform genetic analyses of the DNA with the most up-to-date methods available to identify genetic variations
  • Study in the laboratory why the genetic variations cause the disorder

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ACC; unaffected individuals only if part of a participating ACC family

Exclusion criteria

  • No ACC unaffected individuals only as part of a participating ACC family

Treatment and study plan

Primary outcomes

  1. Identification of genetic elements

    Time frame: at time of identification

    The goal is to identify relevant genes or genetic elements that cause the disease or contribute to the disease progression and severity.

Study contacts

Contact information is provided by the study sponsor or research team.

Ernst J Reichenberger, PhD

CONTACT

[email protected]

860-679-2062

Sponsors and collaborators

Lead sponsor

UConn Health

Other

Registry information

Official study title

Identification of Mutations That Lead to Aplasia Cutis Congenita in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms

Acronym: ACC

Important dates

Study start
2009
Primary completion
2030
Study completion
2030
First posted
Jun 28, 2012
Registry last updated
Apr 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.